ARCHIVES

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

Bioassay Backlog Reports show Increasing Number Of Equivocal Results; Is The Program A Failure?

September 2, 1977

ACS-Roosevelt Awards Go to 19 New Fellows

July 30, 1976

NIH Panel Urges Wider Treatment of Hepatitis C

June 14, 2002

FDA Official Outlines agency’s Views On Efficacy Requirement

June 16, 1999

Centers, Cancer Control Would Get Larger Shares of NCI Increase In House Bill; Grant Total Drops

August 28, 1987